Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Humanised anti-IL-6 receptor monoclonal antibody

EU orphan designation number: EU/3/16/1680   
Active ingredient: Humanised anti-IL-6 receptor monoclonal antibody
Indication: Treatment of neuromyelitis optica spectrum disorders
Sponsor: Chugai Pharma France
100-101 Quartier Boieldieu, Tour Franklin, Arche Sud, 92042 Paris la Défense Cedex, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
29/06/2016 Orphan designation EMA/OD/014/16 (2016)4121 of 27/06/2016
15/01/2019 Transfer of orphan designation EMA/OD/0000003065 (2019)229 of 11/01/2019